Carderock Capital Management Inc Johnson & Johnson Transaction History

Carderock Capital Management Inc

$408 Million
Q3 2024

A detailed history of Carderock Capital Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Carderock Capital Management Inc holds 1,450 shares of JNJ stock, worth $211,482. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,450

Previous 1,500 3.33%

Holding current value

$211,482

Previous $219,000 6.85%

% of portfolio

0.06%

Previous 0.06%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$145.48 - $167.38 $7,273 - $8,369	-50 Reduced 3.33%	1,450 $234,000
Q2 2024 Jul 22, 2024	SELL	$144.38 - $157.78 $14,438 - $15,778	-100 Reduced 6.25%	1,500 $219,000
Q4 2023 Jan 23, 2024	BUY	$145.6 - $158.88 $2,475 - $2,700	17 Added 1.07%	1,600 $250,000
Q3 2023 Oct 23, 2023	BUY	$155.75 - $174.48 $246,552 - $276,201	1,583 New	1,583 $246,000
Q1 2023 Apr 19, 2023	SELL	$151.05 - $180.26 $199,688 - $238,303	-1,322 Reduced 49.48%	1,350 $209,000
Q4 2022 Jan 20, 2023	BUY	$160.2 - $179.79 $87,309 - $97,985	545 Added 25.62%	2,672 $472,000
Q3 2022 Nov 04, 2022	BUY	$161.33 - $179.52 $20,488 - $22,799	127 Added 6.35%	2,127 $347,000
Q2 2022 Jul 21, 2022	SELL	$168.19 - $186.01 $20,014 - $22,135	-119 Reduced 5.62%	2,000 $355,000
Q1 2022 Apr 28, 2022	SELL	$158.14 - $179.59 $34,790 - $39,509	-220 Reduced 9.41%	2,119 $376,000
Q3 2021 Oct 29, 2021	SELL	$161.5 - $179.47 $94,316 - $104,810	-584 Reduced 19.98%	2,339 $378,000
Q2 2021 Jul 30, 2021	SELL	$159.48 - $171.07 $75,753 - $81,258	-475 Reduced 13.98%	2,923 $482,000
Q1 2021 May 07, 2021	BUY	$153.07 - $170.48 $22,654 - $25,231	148 Added 4.55%	3,398 $558,000
Q3 2020 Oct 27, 2020	SELL	$140.38 - $153.83 $149,364 - $163,675	-1,064 Reduced 24.66%	3,250 $484,000
Q2 2020 Aug 04, 2020	SELL	$128.81 - $155.51 $80,506 - $97,193	-625 Reduced 12.65%	4,314 $607,000
Q1 2020 May 11, 2020	SELL	$111.14 - $153.99 $11,114 - $15,399	-100 Reduced 1.98%	4,939 $648,000
Q4 2019 Feb 04, 2020	SELL	$127.5 - $146.44 $6,375 - $7,322	-50 Reduced 0.98%	5,039 $735,000
Q3 2019 Oct 24, 2019	BUY	$126.95 - $142.14 $6,347 - $7,106	50 Added 0.99%	5,089 $658,000
Q2 2019 Jul 15, 2019	SELL	$131.15 - $144.24 $6,557 - $7,212	-50 Reduced 0.98%	5,039 $702,000
Q1 2019 Apr 23, 2019	SELL	$125.72 - $139.79 $1,382 - $1,537	-11 Reduced 0.22%	5,089 $711,000
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $20,514 - $24,689	-167 Reduced 3.17%	5,100 $658,000
Q2 2018 Jul 16, 2018	SELL	$119.4 - $131.76 $133,489 - $147,307	-1,118 Reduced 17.51%	5,267 $639,000
Q1 2018 Apr 27, 2018	SELL	$125.1 - $148.14 $12,510 - $14,813	-100 Reduced 1.54%	6,385 $818,000
Q4 2017 Jan 25, 2018	SELL	$131.22 - $143.62 $91,985 - $100,677	-701 Reduced 9.76%	6,485 $906,000
Q2 2017 Aug 10, 2017	BUY	N/A	7,186	7,186 $951,000

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carderock Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Carderock Capital Management Inc with notifications on news.

Account

Carderock Capital Management Inc Johnson & Johnson Transaction History